Directed in vivo angiogenesis assay and the study of systemic neoangiogenesis in cancer

International Journal of Cancer

Volumn 128, Issue 7, 2011, Pages 1505-1508

  Napoli, Claudio ^a,b   Giordano, Antonio ^b,c,d   Casamassimi, Amelia ^a   Pentimalli, Francesca ^d   Ignarro, Louis J ^e   De Nigris, Filomena ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b TEMPLE UNIVERSITY   (United States)

^c UNIVERSITY OF SIENA   (Italy)

^d CROM Center of Oncology Research Mercogliano   (Italy)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

angiogenesis; cancer; endothelium

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; SILICON;

ADVANCED CANCER; ASSAY; BIOREACTOR; CANCER GROWTH; CANCER INVASION; CARCINOMA; DIRECTED IN VIVO ANGIOGENESIS ASSAY; ENDOTHELIUM CELL; HUMAN; IN VIVO STUDY; LUNG METASTASIS; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REPRODUCIBILITY; REVIEW; SYSTEMIC CIRCULATION; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOMEDICAL RESEARCH; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; MEDICAL ONCOLOGY; MICE; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION;

EID: 79551496459     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25743     Document Type: Review

References (21)

1. Folkman J, Angiogenesis: an organizing principle of drug discovery? Nat Rev Drug Discov 2007; 6: 273-86. (Pubitemid 46505878)
2. Folkman J,. Angiogenesis. Annu Rev Med 2006; 57: 1-18.
3. de Nigris F, Rossiello R, Schiano C, Arra C, Williams-Ignarro S, Barbieri A, Lanza A, Balestrieri A, Giuliano MT, Ignarro LJ, Napoli C,. Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis. Cancer Res 2008; 68: 1797-1808.
4. Guedez L, Rivera AM, Salloum R, Miller ML, Diegmueller JJ, Bungay PM, Stetler-Stevenson WG,. Quantitative assessment of angiogenic response by the directed in vivo angiogenesis assay. Am J Pathol 2003; 162: 1431-1439.
5. de Nigris F, Crudele V, Giovane A, Casamassimi A, Giordano A, Garban HJ, Cacciatore F, Pentimalli F, Marquez-Garban DC, Petrillo A, Cito L, Sommese L, et al. C. CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy. Proc Natl Acad Sci USA 2010; 107: 14484-9.
6. Balestrieri ML, Napoli C,. Novel challenges in exploring peptide ligands and corresponding tissue-specific endothelial receptors. Eur J Cancer 2007; 43: 1242-50.
7. Norrby K,. In vivo models of angiogenesis. J Cell Mol Med 2006; 10: 588-612.
8. Zudaire E, Martínez A, Garayoa M, Pío R, Kaur G, Woolhiser MR, Metcalfe DD, Hook WA, Siraganian RP, Guise TA, Chirgwin JM, Cuttitta F,. Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis. Am J Pathol 2006; 168: 280-91.
9. Martínez A, Zudaire E, Portal-Núñez S, Guédez L, Libutti SK, Stetler-Stevenson WG, Cuttitta F,. Proadrenomedullin NH2-Terminal 20 Peptide Is a potent angiogenic factor, and its inhibition results in reduction of tumor growth. Cancer Res 2004; 64: 6489-94.
10. Bianco C, Strizzi L, Ebert A, Chang C, Rehman A, Normanno N, Guedez L, Salloum R, Ginsburg E, Sun Y, Khan N, Hirota M, et al. Role of human Cripto-1 in tumor angiogenesis. J Natl Cancer Inst 2005; 97: 132-41.
11. Basile JR, Holmbeck K, Bugge TH, Gutkind JS,. MT1-MMP Controls tumor-induced angiogenesis through the release of semaphorin 4D. J Biol Chem 2007; 282: 6899-905.
12. Caldas H, Fangusaro JR, Boué DR, Holloway MP, Altura RA,. Dissecting the role of endothelial SURVIVIN {Delta}Ex3 in angiogenesis. Blood 2007; 109: 1479-89.
13. Wang T, Ward Y, Tian L, Lake R, Guedez L, Stetler-Stevenson WG, Kelly K,. CD97, an adhesion receptor on inflammatory cells, stimulates angiogenesis through binding integrin counterreceptors on endothelial cells. Blood 2005; 105: 2836-44.
14. Chrzanowska-Wodnicka M, Kraus AE, Gale D, White GC 2nd, Vansluys J,. Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient mice. Blood 2008; 111: 2647-56.
15. Zudaire E, Cuesta N, Murty V, Woodson K, Adams L, Gonzalez N, Martínez A, Narayan G, Kirsch I, Franklin W, Hirsch F, Birrer M, et al. The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers. J Clin Invest 2008; 118: 640-50.
16. Yin L, Morishige K, Takahashi T, Hashimoto K, Ogata S, Tsutsumi S, Takata K, Ohta T, Kawagoe J, Takahashi K, Kurachi,. H. Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Mol Cancer Ther 2007; 6: 1517-25.
17. Mabuchi S, Terai Y, Morishige K, Tanabe-Kimura A, Sasaki H, Kanemura M, Tsunetoh S, Tanaka Y, Sakata M, Burger RA, Kimura T, Ohmichi M,. Maintenance treatment with bevacizumab prolongs survival in an in vivo ovarian cancer model. Clin Cancer Res 2008; 14: 7781-9.
18. Liu S, Wang H, Currie BM, Molinolo A, Leung HJ, Moayeri M, Basile JR, Alfano RW, Gutkind JS, Frankel AE, Bugge TH, Leppla SH,. Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature. J Biol Chem 2008; 283: 529-40.
19. Koskimaki JE, Karagiannis ED, Tang BC, Hammers H, Watkins DN, Pili R, Popel AS,. Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model. BMC Cancer 2010; 10: 29.
20. Vu HN, Miller WJ, O'Connor SA, He M, Schafer PH, Payvandi F, Muller GW, Stirling DI, Libutti SK,. CC-5079: a small molecule with MKP1, antiangiogenic, and antitumor activity. J Surg Res 2010; 164: 116-125.
21. Rak J, Milsom C, Yu J,. Vascular determinants of cancer stem cell dormancy-do age and coagulation system play a role? APMIS 2008; 116: 660-76.